These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


284 related items for PubMed ID: 26349160

  • 1. [The importance of electrophysiological tests in early diagnosis of optic nerve dysfunction coexisting with pituitary adenomas--review and own experience].
    Lachewicz E, Lubiński W.
    Klin Oczna; 2015; 117(1):50-5. PubMed ID: 26349160
    [Abstract] [Full Text] [Related]

  • 2. The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.
    Lachowicz E, Lubiński W.
    Doc Ophthalmol; 2018 Dec; 137(3):193-202. PubMed ID: 30374652
    [Abstract] [Full Text] [Related]

  • 3. The clinical value of the multi-channel PVEP and PERG in the diagnosis and management of the patient with pituitary adenoma: a case report.
    Lachowicz E, Lubiński W.
    Doc Ophthalmol; 2018 Aug; 137(1):37-45. PubMed ID: 29968203
    [Abstract] [Full Text] [Related]

  • 4. [Value of mfVEP test in pituitary tumors diagnosis].
    Piekarska A, Lubiński W, Gosławski W, Wieliczko W, Syrenicz A, Olszowski T, Karczewicz D.
    Klin Oczna; 2008 Aug; 110(7-9):247-51. PubMed ID: 19112855
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of N95 amplitude of pattern electroretinogram measured from baseline to N95 trough in the traumatic optic neuropathy.
    Kim KH, Kim US.
    Jpn J Ophthalmol; 2019 May; 63(3):284-288. PubMed ID: 30848395
    [Abstract] [Full Text] [Related]

  • 6. The pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyes.
    Holder GE.
    Eye (Lond); 1997 May; 11 ( Pt 6)():924-34. PubMed ID: 9537157
    [Abstract] [Full Text] [Related]

  • 7. [Electrophysiological tests in early and differential diagnosis of some hereditary retinal and optic nerve diseases].
    Lubińiski W, Palacz O, Karczewicz D.
    Klin Oczna; 2006 May; 108(1-3):93-8. PubMed ID: 16883951
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological assessment of optic nerve disease.
    Holder GE.
    Eye (Lond); 2004 Nov; 18(11):1133-43. PubMed ID: 15534599
    [Abstract] [Full Text] [Related]

  • 9. Identifying preperimetric functional loss in glaucoma: a blue-on-yellow multifocal visual evoked potentials study.
    Arvind H, Graham S, Leaney J, Grigg J, Goldberg I, Billson F, Klistorner A.
    Ophthalmology; 2009 Jun; 116(6):1134-41. PubMed ID: 19395037
    [Abstract] [Full Text] [Related]

  • 10. Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.
    Jayaraman M, Ambika S, Gandhi RA, Bassi SR, Ravi P, Sen P.
    Doc Ophthalmol; 2010 Dec; 121(3):197-204. PubMed ID: 20821036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [How to use of visual evoked potential testing technology reasonable].
    Zhang ZM, Yin ZQ.
    Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1061-3. PubMed ID: 24499690
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease.
    Krasodomska K, Lubiński W, Potemkowski A, Honczarenko K.
    Doc Ophthalmol; 2010 Oct; 121(2):111-21. PubMed ID: 20549299
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.